Projects per year
Personal profile
Keywords
- Blood
- Diagnosis of malignant blood diseases
- Molecular medicine
- gene therapy
- Genetics
- Leukemogenesis and myelodysplastic syndromes
- Leukemogenesis and myelodysplstic syndromes
- Blood
- Leukemia development
- Biological treatment
Fingerprint
Dive into the research topics where Peter Hokland is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Exploring the diagnostic potential of imaging flow cytometry in myelodysplastic syndrome
Bill, M. (Participant), Ludvigsen, M. (Participant), Rosenberg, C. (Participant) & Hokland, P. (Participant)
01/02/2017 → …
Project: Research
-
Characterizing the clonal potential of CD34+CD38-CLEC12A+ cells in patients with myelofibrosis
Bill, M. (Participant), Roug, A. S. (Participant), Herborg, L. L. (Participant), Hokland, P. (Participant), Rosenberg, C. (Participant) & Petersen, M. A. (Participant)
01/01/2017 → 01/01/2020
Project: Research
-
Aldehyde dehydrogenase activity and human Myeloid Inhibitory C-type Lectin-like receptor - A novel approach to identify leukemic stem cells in myelodysplastic syndromes
Steinmüller, L. (Participant), Bill, M. (Participant), Nederby, L. (Participant) & Hokland, P. (Participant)
01/02/2015 → 01/02/2018
Project: Research
-
EVOLUTION OF SUBCLONAL LEUKEMIC POPULATIONS DURING AND AFTER THERAPY IN MDS AND AML
Simonsen, A. T. (Participant), Ommen, H. B. (Project manager), Nyvold, C. G. (Participant), Nederby, L. (Participant) & Hokland, P. (Award holder)
01/12/2014 → 12/04/2019
Project: Research
-
Aldehyde Dehydrogenase Activity - A Novel Marker of Leukemic Stem Cells in Myeloid Neoplasms
Bill, M. (Participant), Nederby, L. (Participant), Roug, A. S. (Participant) & Hokland, P. (Project manager)
01/04/2014 → 01/02/2018
Project: Research
Research output
-
Revisiting CLEC12A as leukaemic stem cell marker in AML: highlighting the necessity of precision diagnostics in patients eligible for targeted therapy
Bill, M., Aggerholm, A., Kjeldsen, E., Roug, A. S., Hokland, P. & Nederby, L., Mar 2019, In: British Journal of Haematology. 184, 5, p. 769-781 13 p.Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review
11 Citations (Scopus) -
The Nobel Prize for Medicine awarded for cancer therapy by inhibition of negative immune regulation
Hokland, P., Hokland, M. & Cotter, F., Dec 2018, In: British Journal of Haematology. 183, 5, p. 698-700 3 p.Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review
13 Citations (Scopus) -
Systematic evaluation of signal-to-noise ratio in variant detection from single cell genome multiple displacement amplification and exome sequencing
Simonsen, A. T., Hansen, M. C., Kjeldsen, E., Møller, P. L., Hindkjær, J. J., Hokland, P. & Aggerholm, A., 2018, In: BMC Genomics. 19, 1, 9 p., 681.Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review
Open Access14 Citations (Scopus) -
Complete donor chimerism following 0/10 HLA-mismatched unrelated donor allogeneic hematopoietic stem cell transplantation
Sørensen, C. D., Møller, B. K., Olesen, G., Hokland, P. & Hokland, M., 1 Dec 2018, In: Bone Marrow Transplantation. 53, 12, p. 1578-1582 5 p.Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review
1 Citation (Scopus) -
Mapping the CLEC12A expression on myeloid progenitors in normal bone marrow; implications for understanding CLEC12A-related cancer stem cell biology
Bill, M., van Kooten Niekerk, P. B., Woll, P. S., Herborg, L. L., Roug, A. S., Hokland, P. & Nederby, L., Apr 2018, In: Journal of Cellular and Molecular Medicine. 22, 4, p. 2311-2318 8 p.Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review
Open Access33 Citations (Scopus)
Activities
-
"Update on the CAR-T cell situation in Europe: expansion, but focus on selecting patients and CRISPR/Cas9 looming in the horizon." Host professor Pa-thai Yenchitsomanus.
Hokland, P. (Lecturer)
9 Feb 2018Activity: Presentations, memberships, employment, ownership and other activities › Lecture and oral contribution
-
"The minimal residual disease concept - from conception towards final clinical recognition" (Professor Danilo Perotti).
Hokland, P. (Lecturer)
25 Aug 2017Activity: Presentations, memberships, employment, ownership and other activities › Lecture and oral contribution
-
"The minimal residual disease concept - from conception towards final clinical recognition" (Professor Lucy Godley).
Hokland, P. (Lecturer)
31 Aug 2017Activity: Presentations, memberships, employment, ownership and other activities › Lecture and oral contribution
-
"The minimal residual disease concept - from conception towards final clinical recognition" (Professor Chris Hourigan).
Hokland, P. (Lecturer)
24 Aug 2017Activity: Presentations, memberships, employment, ownership and other activities › Lecture and oral contribution
-
Contributor to Lex.dk encyclopaedia on blood diseases and investigation of hematopoieses
Hokland, P. (Lecturer)
1 Nov 2024Activity: Presentations, memberships, employment, ownership and other activities › Member of committee, council or board
Prizes
-
Honorary Prized of the Odd Fellow Order, Denmark
Hokland, Peter (Recipient), 26 Apr 2009
Prize: Prizes, scholarships, distinctions
-
-
Hede-Nielsen Fondens hæderspris
Hokland, Peter (Recipient), 1 Jun 1981
Prize: Prizes, scholarships, distinctions
Press/Media
-
-
Interview P1 Orientering om Nobelpriser til Cancer Immunterapi
15/10/2018 → 15/11/2018
2 Media contributions
Press/Media: Press / Media
-
https://dagensmedicin.dk/ny-analyse-banebrydende-kraeftmiddel-dyrt/
15/03/2018
1 Media contribution
Press/Media: Press / Media
-
http://ugeskriftet.dk/nyhed/crispr-er-paa-vej-fra-mus-til-mennesker
08/01/2018
1 Media contribution
Press/Media: Press / Media
-
Rødmossethed kan skyldes blodsygdomme – og være ligeså farligt som forhøjet kolesterol
13/08/2018
1 Media contribution
Press/Media: Press / Media